<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
    
    <title>My New Hugo Site</title>
    <meta name="viewport" content="width=device-width,minimum-scale=1">
    <meta name="description" content="advertisement The agreement comes less than a year since Robert Michael took over as CEO of AbbVie and as the company looks for its next top-selling drugs following the loss of patent protection for its mega blockbuster autoimmune treatment Humira. In a statement, Michael said that the Gubra partnership offers “a compelling opportunity based on the potential to address patient needs while also fostering long-term growth for our company.” STAT&#43; Exclusive Story Already have an account?">
    <meta name="generator" content="Hugo 0.128.0">
    
    
    
      <meta name="robots" content="index, follow">
    
    

    
<link rel="stylesheet" href="/ananke/css/main.min.2438bcafd7af9675c426d1a4afcd16cfff18e4e10f401071e45b5ccd3be40a0d.css" >




    

    
      

    

    

    
      <link rel="canonical" href="https://zhanhuizhang.github.io/posts/20250307_2600563399/">
    

    <meta property="og:url" content="https://zhanhuizhang.github.io/posts/20250307_2600563399/">
  <meta property="og:site_name" content="My New Hugo Site">
  <meta property="og:title" content="My New Hugo Site">
  <meta property="og:description" content="advertisement The agreement comes less than a year since Robert Michael took over as CEO of AbbVie and as the company looks for its next top-selling drugs following the loss of patent protection for its mega blockbuster autoimmune treatment Humira. In a statement, Michael said that the Gubra partnership offers “a compelling opportunity based on the potential to address patient needs while also fostering long-term growth for our company.” STAT&#43; Exclusive Story Already have an account?">
  <meta property="og:locale" content="en_us">
  <meta property="og:type" content="article">
    <meta property="article:section" content="posts">

  <meta itemprop="name" content="My New Hugo Site">
  <meta itemprop="description" content="advertisement The agreement comes less than a year since Robert Michael took over as CEO of AbbVie and as the company looks for its next top-selling drugs following the loss of patent protection for its mega blockbuster autoimmune treatment Humira. In a statement, Michael said that the Gubra partnership offers “a compelling opportunity based on the potential to address patient needs while also fostering long-term growth for our company.” STAT&#43; Exclusive Story Already have an account?">
  <meta itemprop="wordCount" content="110">
  <meta name="twitter:card" content="summary">
  <meta name="twitter:title" content="My New Hugo Site">
  <meta name="twitter:description" content="advertisement The agreement comes less than a year since Robert Michael took over as CEO of AbbVie and as the company looks for its next top-selling drugs following the loss of patent protection for its mega blockbuster autoimmune treatment Humira. In a statement, Michael said that the Gubra partnership offers “a compelling opportunity based on the potential to address patient needs while also fostering long-term growth for our company.” STAT&#43; Exclusive Story Already have an account?">

      
  


    
	
  </head><body class="ma0 avenir bg-near-white production">

    
   
  

  <header>
    <div class="bg-black">
      <nav class="pv3 ph3 ph4-ns" role="navigation">
  <div class="flex-l justify-between items-center center">
    <a href="/" class="f3 fw2 hover-white no-underline white-90 dib">
      
        My New Hugo Site
      
    </a>
    <div class="flex-l items-center">
      

      
      <div class="ananke-socials"></div>

    </div>
  </div>
</nav>

    </div>
  </header>



    <main class="pb7" role="main">
      
  
  
  <article class="flex-l flex-wrap justify-between mw8 center ph3">
    <header class="mt4 w-100">
      <aside class="instapaper_ignoref b helvetica tracked ttu">
          
        Posts
      </aside><div id="sharing" class="mt3 ananke-socials"></div>
<h1 class="f1 athelas mt3 mb1"></h1>
      
      
      

      
      
    </header>
    <div class="nested-copy-line-height lh-copy serif f4 nested-links mid-gray pr4-l w-two-thirds-l"><p>advertisement The agreement comes less than a year since Robert Michael took over as CEO of AbbVie and as the company looks for its next top-selling drugs following the loss of patent protection for its mega blockbuster autoimmune treatment Humira. In a statement, Michael said that the Gubra partnership offers “a compelling opportunity based on the potential to address patient needs while also fostering long-term growth for our company.” STAT+ Exclusive Story Already have an account? Log in Monthly $39 Totals $468 per year Totals $468 per year Starter $30 for 3 months, then $399/year Then $399/year Annual $399 Save 15% Save 15% 11+ Users Custom Savings start at 25%!</p>
<ul class="pa0">
  
</ul>
<div class="mt6 instapaper_ignoref">
      
      
      </div>
    </div>

    <aside class="w-30-l mt6-l">




</aside>

  </article>

    </main>
    <footer class="bg-black bottom-0 w-100 pa3" role="contentinfo">
  <div class="flex justify-between">
  <a class="f4 fw4 hover-white no-underline white-70 dn dib-ns pv2 ph3" href="https://zhanhuizhang.github.io/" >
    &copy;  My New Hugo Site 2025 
  </a>
    <div><div class="ananke-socials"></div>
</div>
  </div>
</footer>

  </body>
</html>
